Position in ASND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$530,403,126
+$82,356,967 QoQ
Shares Held
1,988,614
+1.5% QoQ
Ownership
3.03%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#9
of 308 holders
Holding Since
Mar 2022
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Capital International Investors holds $7,948,137,729 across 16 Biotechnology names. ASND ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,695,144 | $2,332,218,879 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,273,770 | $1,977,800,283 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,210,221 | $1,199,786,678 | |
| 4 | INSM |
INSMED Inc
|
8,238,124 | $878,348,780 | |
| 5 | ASND |
Ascendis Pharma A/S
This page
|
1,988,614 | $530,403,126 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,361,639 | $142,548,530 | |
| 7 | DFTX |
Definium Therapeutics, Inc.
|
2,963,410 | $139,398,806 | |
| 8 | COAG |
Hemab Therapeutics Holdings, Inc.
|
3,603,876 | $132,370,365 |
All Filings in ASND
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $530,403,126 | 1,988,614 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $448,046,159 | 1,958,843 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $653,355,205 | 3,063,943 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $608,481,066 | 3,060,616 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $525,900,290 | 3,046,931 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $448,065,081 | 2,874,792 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $394,183,489 | 2,863,249 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $314,953,020 | 2,109,390 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $286,984,161 | 2,104,298 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $331,260,635 | 2,191,312 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $274,730,704 | 2,181,268 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $203,053,002 | 2,168,443 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $178,077,936 | 1,995,271 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $213,271,945 | 1,989,106 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $191,499,473 | 1,567,997 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $136,246,510 | 1,319,451 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $121,500,672 | 1,307,021 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $28,894,266 | 246,202 | Shares | Defined | 2022-05-19 | |
| No filing history on record for this holder in this stock. | ||||||